Get started
Author

Stephen P. Jung

Inhibiting expression of specific genes in mammalian cells with 5′ end-mutated U1 small nuclear RNAs targeted to terminal exons of pre-mRNA
2003 · Puri Fortes, Yolanda Cuevas, et al. · Proceedings of the National Academy of Sciences · 74
Requirements for gene silencing mediated by U1 snRNA binding to a target sequence
2008 · Xabi Abad, Maria Vera, et al. · Nucleic Acids Research · 54
PDF
Structure–Activity Relationship (SAR) Optimization of 6-(Indol-2-yl)pyridine-3-sulfonamides: Identification of Potent, Selective, and Orally Bioavailable Small Molecules Targeting Hepatitis C (HCV) NS4B
2013 · Nanjing Zhang, Xiaoyan Zhang, et al. · Journal of Medicinal Chemistry · 44
Comparison of pharmaceutical properties and biological activities of prednisolone, deflazacort, and vamorolone in DMD disease models
2023 · Grace Liu, Philip Lipari, et al. · Human Molecular Genetics · 27
PDF
Identification of PTC725, an Orally Bioavailable Small Molecule That Selectively Targets the Hepatitis C Virus NS4B Protein
2013 · Zhengxian Gu, Jason D. Graci, et al. · Antimicrobial Agents and Chemotherapy · 21
PDF
Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4B
2015 · Nanjing Zhang, Anthony Turpoff, et al. · Bioorganic & Medicinal Chemistry Letters · 19
Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder
2024 · Gregory Voronin, Jana Narasimhan, et al. · Molecular Therapy · 16
6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4B
2015 · Guangming Chen, Hongyu Ren, et al. · Bioorganic & Medicinal Chemistry Letters · 16
Development of an oral treatment that rescues gait ataxia and retinal degeneration in a phenotypic mouse model of familial dysautonomia
2023 · Elisabetta Morini, Anil Chekuri, et al. · The American Journal of Human Genetics · 15
PDF
The Risk of Pneumonia in Older Adults Using Nonbenzodiazepine Hypnotics
2016 · Stephen Jung, Michele M. Spence, et al. · Journal of Managed Care & Specialty Pharmacy · 11
PDF
T.P.7 Small molecule compounds correct alternative splicing of the SMN2 gene and restore SMN protein expression and function
2012 · N. Naryshkin, J. Narasimhan, et al. · Neuromuscular Disorders · 6
PTC725, an NS4B-Targeting Compound, Inhibits a Hepatitis C Virus Genotype 3 Replicon, as Predicted by Genome Sequence Analysis and Determined Experimentally
2016 · Jason D. Graci, Stephen P. Jung, et al. · Antimicrobial Agents and Chemotherapy · 4
PDF
Evaluation of the Biodistribution, Efficacy, and Side-Effect Profile of Deflazacort, Prednisolone and Vamorolone in a DMD Mouse Model (S34.010)
2023 · Grace Liu, Phil Lipari, et al. · Neurology
Author response: Ribonucleotide reductase, a novel drug target for gonorrhea
2021 · Jana Narasimhan, Suzanne Letinski, et al. · eLife
Works count: 14
Citation count: 307
H-index: 10
I10-index: 10
Year
Topic
Type